Pfizer-Seagen: Acquisition in the works
Pfizer strengthens its oncology portfolio by acquiring Seagen, the biotech specialist in antibody-drug conjugates technology.
ADVERTISEMENT
About Margarita Milidakis
This author has not written his bio yet.
But we are proud to say that Margarita Milidakis contributed 42 entries already.
Entries by Margarita Milidakis
Collaboration to fight cancer
The charity Cancer Research UK and UCB SA collaborate on the development of two potential cures for cancer.
Noema Pharma AG closes Series B financing
Noema Pharma AG receives €104m in oversubscribed Series B financing round to advance its central nervous system pipeline.
Money for AI-powered drug discovery
Antiverse Ltd.s AI identified eight antibodies with therapeutic potential for humans and raised €2.8m in funding for continued in-house development.
Upping sustainability in pharma packaging
How to make pharma packaging sustainable was one of the major discussion topics at PHARMAPACK 2023.
Novo Holdings invests into standardisation of LC-MS-based proteomics
Evosep APS has inked a $40m funding deal with Novo Holdings A/S that is aimed to advance standardised clinical LC-MS-based drug discovery and diagnostic multi-marker tests.
Collaboration to develop mRNA vaccine against betacoronaviruses
CEPI fights the betacoronaviruses by funding Ethris GmbH and DIOSynVax Ltd and their joint effort to advance their work on an mRNA vaccine.
First allogeneic cancer immunotherapy hits market
Atara Biotherapeutics Inc. and Pierre Fabre SA announced the approval of Tabelecleucel, a therapy for a rare and potentially fatal malignancy.
€72M from Novo´s REPAIR Impact Fund for Group B Streptococcus vaccines
MinervaX inks €72m financing deal with Novo Holdings REPAIR Impact Fund to develop a vaccine against Group B Streptococcus.
A ray of hope in leukaemia
A child with recurrent T-cell leukaemia was given base-edited T-cells in a world-first application of a base-edited cell therapy.